Physicochemical Properties
| Molecular Formula | C5H2CL3NO |
| Molecular Weight | 198.43 |
| Exact Mass | 196.92 |
| CAS # | 6515-38-4 |
| Related CAS # | 37439-34-2 (hydrochloride salt) |
| PubChem CID | 23017 |
| Appearance | White to off-white solid powder |
| Density | 1.7±0.1 g/cm3 |
| Boiling Point | 325.0±37.0 °C at 760 mmHg |
| Melting Point | 328-330ºC |
| Flash Point | 150.4±26.5 °C |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.617 |
| LogP | 2.16 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Heavy Atom Count | 10 |
| Complexity | 243 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | WCYYAQFQZQEUEN-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C5H2Cl3NO/c6-2-1-3(7)5(10)9-4(2)8/h1H,(H,9,10) |
| Chemical Name | 3,5,6-trichloro-1H-pyridin-2-one |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ADME/Pharmacokinetics |
Metabolism / Metabolites 3,5,6-Trichloro-2-pyridinol is a known human metabolite of Chlorpyrifos-oxon and Chlorpyrifos. |
| References |
[1]. Novel gene clusters and metabolic pathway involved in 3,5,6-trichloro-2-pyridinol degradation by Ralstonia sp. strain T6. Appl Environ Microbiol. 2013 Dec;79(23):7445-53. |
| Additional Infomation |
3,5,6-trichloro-2-pyridinol is a hydroxypyridine that is pyridin-2-ol substituted by chloro groups at positions 3,5 and 6. It is a metabolite of the agrochemical chlorpyrifos. It has a role as a human urinary metabolite and a human xenobiotic metabolite. It is a chloropyridine and a hydroxypyridine. It is a tautomer of a 3,5,6-trichloropyridine-2-one. 3,5,6-Trichloro-2-pyridinol has been reported in Bos taurus and Euglena gracilis with data available. |
Solubility Data
| Solubility (In Vitro) | DMSO: 32.5 mg/mL (163.79 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 3.25 mg/mL (16.38 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 32.5 mg/mL clear DMSO stock solution to 400 μL of PEG300 and mix evenly; then add 50 μL of Tween-80 to the above solution and mix evenly; then add 450 μL of normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 3.25 mg/mL (16.38 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 32.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.0396 mL | 25.1978 mL | 50.3956 mL | |
| 5 mM | 1.0079 mL | 5.0396 mL | 10.0791 mL | |
| 10 mM | 0.5040 mL | 2.5198 mL | 5.0396 mL |